Cancel
Greg Moeck
Senior Vice President, Microbiology
@
Venatorx Pharmaceuticals
9q266@g25qiq47.85q
Sign up to see email
See Linkedin
Known information
- Received a Ph.D. in Microbiology and Immunology from McGill University in Montreal, Quebec.
- Conducted post-doctoral research at the University of Paris XI on iron acquisition in gram-negative bacterial pathogens.
- Was a Fellow of the Natural Sciences and Engineering Research Council of Canada and the Ministry of Foreign Affairs, France.
- Has published over 50 papers in peer-reviewed journals.
- Co-authored three book chapters.
- Is co-inventor on four patents relating to methods of treatment of bacterial infections.
- Previously served as Vice President, Biology at The Medicines Company.
- Was Senior Director of Biology at Targanta Therapeutics.
About Venatorx Pharmaceuticals
Venatorx Pharmaceuticals, founded in June 2010, focuses on developing novel anti-infectives to treat multi-drug-resistant bacterial and hard-to-treat viral infections. Their lead asset, cefepime-taniborbactam, has completed a Phase 3 study for complicated urinary tract infections and is under FDA review.
Report inaccurate information
